nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2E1—Fingolimod—multiple sclerosis	0.148	0.191	CbGbCtD
Isoniazid—CYP2A6—Prednisolone—multiple sclerosis	0.0928	0.12	CbGbCtD
Isoniazid—CYP2D6—Fingolimod—multiple sclerosis	0.0706	0.0909	CbGbCtD
Isoniazid—CYP2E1—Mitoxantrone—multiple sclerosis	0.0697	0.0897	CbGbCtD
Isoniazid—CYP2A6—Dexamethasone—multiple sclerosis	0.0547	0.0705	CbGbCtD
Isoniazid—CYP3A4—Fingolimod—multiple sclerosis	0.0449	0.0578	CbGbCtD
Isoniazid—CYP2C19—Prednisone—multiple sclerosis	0.0363	0.0467	CbGbCtD
Isoniazid—CYP2E1—Dexamethasone—multiple sclerosis	0.0361	0.0465	CbGbCtD
Isoniazid—CYP3A4—Methylprednisolone—multiple sclerosis	0.0289	0.0373	CbGbCtD
Isoniazid—CYP2C8—Dexamethasone—multiple sclerosis	0.027	0.0347	CbGbCtD
Isoniazid—CYP2C19—Dexamethasone—multiple sclerosis	0.0226	0.0291	CbGbCtD
Isoniazid—CYP3A4—Triamcinolone—multiple sclerosis	0.0219	0.0282	CbGbCtD
Isoniazid—CYP3A4—Mitoxantrone—multiple sclerosis	0.0211	0.0272	CbGbCtD
Isoniazid—CYP2C9—Dexamethasone—multiple sclerosis	0.0188	0.0242	CbGbCtD
Isoniazid—CYP3A4—Betamethasone—multiple sclerosis	0.0188	0.0242	CbGbCtD
Isoniazid—CYP3A4—Prednisolone—multiple sclerosis	0.0186	0.0239	CbGbCtD
Isoniazid—CYP3A4—Prednisone—multiple sclerosis	0.0175	0.0226	CbGbCtD
Isoniazid—CYP2D6—Dexamethasone—multiple sclerosis	0.0172	0.0222	CbGbCtD
Isoniazid—CYP3A4—Dexamethasone—multiple sclerosis	0.0109	0.0141	CbGbCtD
Isoniazid—Neurotoxicity—Cladribine—multiple sclerosis	0.00579	0.0307	CcSEcCtD
Isoniazid—Metabolic acidosis—Cladribine—multiple sclerosis	0.00568	0.0301	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Azathioprine—multiple sclerosis	0.00547	0.029	CcSEcCtD
Isoniazid—Liver injury—Fingolimod—multiple sclerosis	0.00471	0.025	CcSEcCtD
Isoniazid—Atrophy—Prednisolone—multiple sclerosis	0.00371	0.0197	CcSEcCtD
Isoniazid—Atrophy—Triamcinolone—multiple sclerosis	0.00342	0.0181	CcSEcCtD
Isoniazid—Atrophy—Methylprednisolone—multiple sclerosis	0.00341	0.0181	CcSEcCtD
Isoniazid—Diabetic—Methylprednisolone—multiple sclerosis	0.00333	0.0176	CcSEcCtD
Isoniazid—Atrophy—Betamethasone—multiple sclerosis	0.0031	0.0164	CcSEcCtD
Isoniazid—Atrophy—Dexamethasone—multiple sclerosis	0.0031	0.0164	CcSEcCtD
Isoniazid—Diabetic—Betamethasone—multiple sclerosis	0.00303	0.016	CcSEcCtD
Isoniazid—Diabetic—Dexamethasone—multiple sclerosis	0.00303	0.016	CcSEcCtD
Isoniazid—Neuritis—Cladribine—multiple sclerosis	0.00301	0.0159	CcSEcCtD
Isoniazid—Metabolic acidosis—Methylprednisolone—multiple sclerosis	0.00281	0.0149	CcSEcCtD
Isoniazid—Atrophy—Prednisone—multiple sclerosis	0.0027	0.0143	CcSEcCtD
Isoniazid—Diabetic—Methotrexate—multiple sclerosis	0.0022	0.0117	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Methotrexate—multiple sclerosis	0.0022	0.0117	CcSEcCtD
Isoniazid—Liver injury—Azathioprine—multiple sclerosis	0.00217	0.0115	CcSEcCtD
Isoniazid—Aplastic anaemia—Cladribine—multiple sclerosis	0.00211	0.0112	CcSEcCtD
Isoniazid—NAT2—pineal body—multiple sclerosis	0.00203	0.713	CbGeAlD
Isoniazid—Systemic lupus erythematosus—Triamcinolone—multiple sclerosis	0.00201	0.0107	CcSEcCtD
Isoniazid—Optic neuritis—Prednisolone—multiple sclerosis	0.00197	0.0104	CcSEcCtD
Isoniazid—Neurotoxicity—Methotrexate—multiple sclerosis	0.0019	0.0101	CcSEcCtD
Isoniazid—Vasculitis—Azathioprine—multiple sclerosis	0.00187	0.00992	CcSEcCtD
Isoniazid—Hepatocellular injury—Azathioprine—multiple sclerosis	0.00183	0.00968	CcSEcCtD
Isoniazid—Optic neuritis—Triamcinolone—multiple sclerosis	0.00181	0.0096	CcSEcCtD
Isoniazid—Optic neuritis—Methylprednisolone—multiple sclerosis	0.00181	0.00957	CcSEcCtD
Isoniazid—Aplastic anaemia—Azathioprine—multiple sclerosis	0.00171	0.00909	CcSEcCtD
Isoniazid—Optic neuritis—Dexamethasone—multiple sclerosis	0.00164	0.00871	CcSEcCtD
Isoniazid—Optic neuritis—Betamethasone—multiple sclerosis	0.00164	0.00871	CcSEcCtD
Isoniazid—Neuritis—Prednisolone—multiple sclerosis	0.00162	0.0086	CcSEcCtD
Isoniazid—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.00152	0.00804	CcSEcCtD
Isoniazid—Neuritis—Triamcinolone—multiple sclerosis	0.00149	0.00791	CcSEcCtD
Isoniazid—Neuritis—Methylprednisolone—multiple sclerosis	0.00149	0.00789	CcSEcCtD
Isoniazid—Optic neuritis—Prednisone—multiple sclerosis	0.00143	0.00758	CcSEcCtD
Isoniazid—Eosinophilia—Cladribine—multiple sclerosis	0.00139	0.00739	CcSEcCtD
Isoniazid—Neuritis—Dexamethasone—multiple sclerosis	0.00135	0.00717	CcSEcCtD
Isoniazid—Neuritis—Betamethasone—multiple sclerosis	0.00135	0.00717	CcSEcCtD
Isoniazid—Paraesthesia—Fingolimod—multiple sclerosis	0.00127	0.00673	CcSEcCtD
Isoniazid—Vasculitis—Prednisolone—multiple sclerosis	0.00124	0.00658	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00122	0.00647	CcSEcCtD
Isoniazid—Fatigue—Fingolimod—multiple sclerosis	0.00122	0.00646	CcSEcCtD
Isoniazid—Eruption—Methotrexate—multiple sclerosis	0.0012	0.00634	CcSEcCtD
Isoniazid—Neuritis—Prednisone—multiple sclerosis	0.00118	0.00625	CcSEcCtD
Isoniazid—Vasculitis—Triamcinolone—multiple sclerosis	0.00114	0.00605	CcSEcCtD
Isoniazid—Vasculitis—Methylprednisolone—multiple sclerosis	0.00114	0.00603	CcSEcCtD
Isoniazid—Memory impairment—Prednisone—multiple sclerosis	0.00112	0.00594	CcSEcCtD
Isoniazid—Vasculitis—Dexamethasone—multiple sclerosis	0.00103	0.00549	CcSEcCtD
Isoniazid—Vasculitis—Betamethasone—multiple sclerosis	0.00103	0.00549	CcSEcCtD
Isoniazid—Asthenia—Fingolimod—multiple sclerosis	0.00101	0.00537	CcSEcCtD
Isoniazid—Diabetes mellitus—Prednisolone—multiple sclerosis	0.00101	0.00536	CcSEcCtD
Isoniazid—Agranulocytosis—Azathioprine—multiple sclerosis	0.000953	0.00505	CcSEcCtD
Isoniazid—Diabetes mellitus—Triamcinolone—multiple sclerosis	0.000929	0.00493	CcSEcCtD
Isoniazid—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.000927	0.00491	CcSEcCtD
Isoniazid—Ill-defined disorder—Cladribine—multiple sclerosis	0.000911	0.00483	CcSEcCtD
Isoniazid—Vasculitis—Prednisone—multiple sclerosis	0.000901	0.00478	CcSEcCtD
Isoniazid—Malaise—Cladribine—multiple sclerosis	0.000885	0.00469	CcSEcCtD
Isoniazid—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.000843	0.00447	CcSEcCtD
Isoniazid—Diabetes mellitus—Betamethasone—multiple sclerosis	0.000843	0.00447	CcSEcCtD
Isoniazid—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.000835	0.00443	CcSEcCtD
Isoniazid—Discomfort—Cladribine—multiple sclerosis	0.000825	0.00438	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—multiple sclerosis	0.000808	0.00429	CcSEcCtD
Isoniazid—NAT2—Biological oxidations—CYP24A1—multiple sclerosis	0.000808	0.0254	CbGpPWpGaD
Isoniazid—NAT2—Biological oxidations—CYP27B1—multiple sclerosis	0.000808	0.0254	CbGpPWpGaD
Isoniazid—Jaundice—Mitoxantrone—multiple sclerosis	0.000805	0.00427	CcSEcCtD
Isoniazid—NAT2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000797	0.0251	CbGpPWpGaD
Isoniazid—NAT2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000797	0.0251	CbGpPWpGaD
Isoniazid—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000787	0.00418	CcSEcCtD
Isoniazid—Thrombocytopenia—Cladribine—multiple sclerosis	0.000784	0.00416	CcSEcCtD
Isoniazid—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00077	0.00408	CcSEcCtD
Isoniazid—Anorexia—Cladribine—multiple sclerosis	0.000763	0.00405	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—multiple sclerosis	0.000753	0.00399	CcSEcCtD
Isoniazid—Hepatitis—Mitoxantrone—multiple sclerosis	0.000741	0.00393	CcSEcCtD
Isoniazid—Ill-defined disorder—Azathioprine—multiple sclerosis	0.00074	0.00393	CcSEcCtD
Isoniazid—Diabetes mellitus—Prednisone—multiple sclerosis	0.000734	0.00389	CcSEcCtD
Isoniazid—Malaise—Azathioprine—multiple sclerosis	0.00072	0.00382	CcSEcCtD
Isoniazid—Paraesthesia—Cladribine—multiple sclerosis	0.000719	0.00381	CcSEcCtD
Isoniazid—Psychotic disorder—Betamethasone—multiple sclerosis	0.000716	0.0038	CcSEcCtD
Isoniazid—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000716	0.0038	CcSEcCtD
Isoniazid—Decreased appetite—Cladribine—multiple sclerosis	0.000696	0.00369	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000691	0.00367	CcSEcCtD
Isoniazid—Fatigue—Cladribine—multiple sclerosis	0.000691	0.00366	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—multiple sclerosis	0.00069	0.00366	CcSEcCtD
Isoniazid—Discomfort—Azathioprine—multiple sclerosis	0.000671	0.00356	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000664	0.00352	CcSEcCtD
Isoniazid—Feeling abnormal—Cladribine—multiple sclerosis	0.00066	0.0035	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—multiple sclerosis	0.000658	0.00349	CcSEcCtD
Isoniazid—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000638	0.00338	CcSEcCtD
Isoniazid—Body temperature increased—Cladribine—multiple sclerosis	0.000633	0.00336	CcSEcCtD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000626	0.0197	CbGpPWpGaD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000626	0.0197	CbGpPWpGaD
Isoniazid—Lymphadenopathy—Methotrexate—multiple sclerosis	0.000625	0.00332	CcSEcCtD
Isoniazid—Psychotic disorder—Prednisone—multiple sclerosis	0.000624	0.00331	CcSEcCtD
Isoniazid—CYP2A6—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000615	0.0194	CbGpPWpGaD
Isoniazid—Diabetes mellitus—Methotrexate—multiple sclerosis	0.000614	0.00325	CcSEcCtD
Isoniazid—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00061	0.00324	CcSEcCtD
Isoniazid—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000609	0.00323	CcSEcCtD
Isoniazid—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000599	0.00317	CcSEcCtD
Isoniazid—Hypersensitivity—Cladribine—multiple sclerosis	0.00059	0.00313	CcSEcCtD
Isoniazid—Malaise—Mitoxantrone—multiple sclerosis	0.000582	0.00308	CcSEcCtD
Isoniazid—Asthenia—Cladribine—multiple sclerosis	0.000575	0.00305	CcSEcCtD
Isoniazid—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000572	0.00303	CcSEcCtD
Isoniazid—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000572	0.00303	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000562	0.00298	CcSEcCtD
Isoniazid—Convulsion—Mitoxantrone—multiple sclerosis	0.000559	0.00296	CcSEcCtD
Isoniazid—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000554	0.00294	CcSEcCtD
Isoniazid—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000554	0.00294	CcSEcCtD
Isoniazid—Discomfort—Mitoxantrone—multiple sclerosis	0.000543	0.00288	CcSEcCtD
Isoniazid—Feeling abnormal—Azathioprine—multiple sclerosis	0.000537	0.00285	CcSEcCtD
Isoniazid—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000515	0.00273	CcSEcCtD
Isoniazid—Body temperature increased—Azathioprine—multiple sclerosis	0.000515	0.00273	CcSEcCtD
Isoniazid—Vomiting—Cladribine—multiple sclerosis	0.000509	0.0027	CcSEcCtD
Isoniazid—Rash—Cladribine—multiple sclerosis	0.000505	0.00268	CcSEcCtD
Isoniazid—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000503	0.0158	CbGpPWpGaD
Isoniazid—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000503	0.0158	CbGpPWpGaD
Isoniazid—Anorexia—Mitoxantrone—multiple sclerosis	0.000502	0.00266	CcSEcCtD
Isoniazid—Hyperglycaemia—Prednisone—multiple sclerosis	0.000498	0.00264	CcSEcCtD
Isoniazid—CYP2A6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000497	0.0156	CbGpPWpGaD
Isoniazid—CYP2A6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000497	0.0156	CbGpPWpGaD
Isoniazid—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000491	0.0026	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000482	0.00256	CcSEcCtD
Isoniazid—Hypersensitivity—Azathioprine—multiple sclerosis	0.00048	0.00254	CcSEcCtD
Isoniazid—Malaise—Prednisolone—multiple sclerosis	0.000477	0.00253	CcSEcCtD
Isoniazid—Nausea—Cladribine—multiple sclerosis	0.000476	0.00252	CcSEcCtD
Isoniazid—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000473	0.00251	CcSEcCtD
Isoniazid—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000463	0.00246	CcSEcCtD
Isoniazid—Convulsion—Prednisolone—multiple sclerosis	0.000459	0.00243	CcSEcCtD
Isoniazid—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000458	0.00243	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—multiple sclerosis	0.000457	0.00242	CcSEcCtD
Isoniazid—Fatigue—Mitoxantrone—multiple sclerosis	0.000454	0.00241	CcSEcCtD
Isoniazid—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000452	0.00239	CcSEcCtD
Isoniazid—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000451	0.00239	CcSEcCtD
Isoniazid—Discomfort—Prednisolone—multiple sclerosis	0.000445	0.00236	CcSEcCtD
Isoniazid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000441	0.0139	CbGpPWpGaD
Isoniazid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000441	0.0139	CbGpPWpGaD
Isoniazid—Malaise—Triamcinolone—multiple sclerosis	0.000439	0.00233	CcSEcCtD
Isoniazid—Malaise—Methylprednisolone—multiple sclerosis	0.000438	0.00232	CcSEcCtD
Isoniazid—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000434	0.0023	CcSEcCtD
Isoniazid—Convulsion—Triamcinolone—multiple sclerosis	0.000422	0.00224	CcSEcCtD
Isoniazid—Convulsion—Methylprednisolone—multiple sclerosis	0.000421	0.00223	CcSEcCtD
Isoniazid—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000416	0.00221	CcSEcCtD
Isoniazid—Vomiting—Azathioprine—multiple sclerosis	0.000414	0.0022	CcSEcCtD
Isoniazid—Rash—Azathioprine—multiple sclerosis	0.000411	0.00218	CcSEcCtD
Isoniazid—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.00041	0.00217	CcSEcCtD
Isoniazid—Ill-defined disorder—Betamethasone—multiple sclerosis	0.00041	0.00217	CcSEcCtD
Isoniazid—Discomfort—Triamcinolone—multiple sclerosis	0.000409	0.00217	CcSEcCtD
Isoniazid—Discomfort—Methylprednisolone—multiple sclerosis	0.000408	0.00217	CcSEcCtD
Isoniazid—CYP2A6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000408	0.0128	CbGpPWpGaD
Isoniazid—CYP2A6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000408	0.0128	CbGpPWpGaD
Isoniazid—Malaise—Dexamethasone—multiple sclerosis	0.000398	0.00211	CcSEcCtD
Isoniazid—Malaise—Betamethasone—multiple sclerosis	0.000398	0.00211	CcSEcCtD
Isoniazid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000398	0.0125	CbGpPWpGaD
Isoniazid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000398	0.0125	CbGpPWpGaD
Isoniazid—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000392	0.0124	CbGpPWpGaD
Isoniazid—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000392	0.0124	CbGpPWpGaD
Isoniazid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000388	0.00206	CcSEcCtD
Isoniazid—Paraesthesia—Prednisolone—multiple sclerosis	0.000388	0.00206	CcSEcCtD
Isoniazid—Nausea—Azathioprine—multiple sclerosis	0.000387	0.00205	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—multiple sclerosis	0.000384	0.00203	CcSEcCtD
Isoniazid—Convulsion—Betamethasone—multiple sclerosis	0.000383	0.00203	CcSEcCtD
Isoniazid—Convulsion—Dexamethasone—multiple sclerosis	0.000383	0.00203	CcSEcCtD
Isoniazid—Asthenia—Mitoxantrone—multiple sclerosis	0.000378	0.002	CcSEcCtD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000377	0.0119	CbGpPWpGaD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000377	0.0119	CbGpPWpGaD
Isoniazid—Discomfort—Dexamethasone—multiple sclerosis	0.000371	0.00197	CcSEcCtD
Isoniazid—Discomfort—Betamethasone—multiple sclerosis	0.000371	0.00197	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—multiple sclerosis	0.000369	0.00196	CcSEcCtD
Isoniazid—Ill-defined disorder—Prednisone—multiple sclerosis	0.000357	0.00189	CcSEcCtD
Isoniazid—Paraesthesia—Triamcinolone—multiple sclerosis	0.000357	0.00189	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisolone—multiple sclerosis	0.000356	0.00189	CcSEcCtD
Isoniazid—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000356	0.00189	CcSEcCtD
Isoniazid—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000353	0.00187	CcSEcCtD
Isoniazid—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000353	0.00187	CcSEcCtD
Isoniazid—Dyspepsia—Triamcinolone—multiple sclerosis	0.00035	0.00185	CcSEcCtD
Isoniazid—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000349	0.00185	CcSEcCtD
Isoniazid—Malaise—Prednisone—multiple sclerosis	0.000347	0.00184	CcSEcCtD
Isoniazid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000344	0.0108	CbGpPWpGaD
Isoniazid—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000344	0.0108	CbGpPWpGaD
Isoniazid—Anorexia—Betamethasone—multiple sclerosis	0.000344	0.00182	CcSEcCtD
Isoniazid—Anorexia—Dexamethasone—multiple sclerosis	0.000344	0.00182	CcSEcCtD
Isoniazid—Fatigue—Triamcinolone—multiple sclerosis	0.000342	0.00182	CcSEcCtD
Isoniazid—Fatigue—Methylprednisolone—multiple sclerosis	0.000342	0.00181	CcSEcCtD
Isoniazid—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000339	0.0107	CbGpPWpGaD
Isoniazid—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000339	0.0107	CbGpPWpGaD
Isoniazid—Vomiting—Mitoxantrone—multiple sclerosis	0.000335	0.00177	CcSEcCtD
Isoniazid—Convulsion—Prednisone—multiple sclerosis	0.000333	0.00177	CcSEcCtD
Isoniazid—Rash—Mitoxantrone—multiple sclerosis	0.000332	0.00176	CcSEcCtD
Isoniazid—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000327	0.00174	CcSEcCtD
Isoniazid—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000327	0.00173	CcSEcCtD
Isoniazid—Paraesthesia—Dexamethasone—multiple sclerosis	0.000324	0.00172	CcSEcCtD
Isoniazid—Paraesthesia—Betamethasone—multiple sclerosis	0.000324	0.00172	CcSEcCtD
Isoniazid—Discomfort—Prednisone—multiple sclerosis	0.000323	0.00172	CcSEcCtD
Isoniazid—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000322	0.0102	CbGpPWpGaD
Isoniazid—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000322	0.0102	CbGpPWpGaD
Isoniazid—Hypersensitivity—Prednisolone—multiple sclerosis	0.000318	0.00169	CcSEcCtD
Isoniazid—Dyspepsia—Betamethasone—multiple sclerosis	0.000317	0.00168	CcSEcCtD
Isoniazid—Dyspepsia—Dexamethasone—multiple sclerosis	0.000317	0.00168	CcSEcCtD
Isoniazid—Body temperature increased—Triamcinolone—multiple sclerosis	0.000314	0.00166	CcSEcCtD
Isoniazid—Decreased appetite—Betamethasone—multiple sclerosis	0.000313	0.00166	CcSEcCtD
Isoniazid—Decreased appetite—Dexamethasone—multiple sclerosis	0.000313	0.00166	CcSEcCtD
Isoniazid—Nausea—Mitoxantrone—multiple sclerosis	0.000313	0.00166	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000311	0.00165	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000311	0.00165	CcSEcCtD
Isoniazid—Fatigue—Dexamethasone—multiple sclerosis	0.000311	0.00165	CcSEcCtD
Isoniazid—Fatigue—Betamethasone—multiple sclerosis	0.000311	0.00165	CcSEcCtD
Isoniazid—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000307	0.00966	CbGpPWpGaD
Isoniazid—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000307	0.00966	CbGpPWpGaD
Isoniazid—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000303	0.00954	CbGpPWpGaD
Isoniazid—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000303	0.00954	CbGpPWpGaD
Isoniazid—Anorexia—Prednisone—multiple sclerosis	0.000299	0.00159	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000298	0.00158	CcSEcCtD
Isoniazid—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000297	0.00157	CcSEcCtD
Isoniazid—Feeling abnormal—Betamethasone—multiple sclerosis	0.000297	0.00157	CcSEcCtD
Isoniazid—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000293	0.00155	CcSEcCtD
Isoniazid—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000292	0.00155	CcSEcCtD
Isoniazid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000291	0.00915	CbGpPWpGaD
Isoniazid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000291	0.00915	CbGpPWpGaD
Isoniazid—Malaise—Methotrexate—multiple sclerosis	0.00029	0.00154	CcSEcCtD
Isoniazid—Asthenia—Triamcinolone—multiple sclerosis	0.000285	0.00151	CcSEcCtD
Isoniazid—Body temperature increased—Dexamethasone—multiple sclerosis	0.000285	0.00151	CcSEcCtD
Isoniazid—Body temperature increased—Betamethasone—multiple sclerosis	0.000285	0.00151	CcSEcCtD
Isoniazid—Asthenia—Methylprednisolone—multiple sclerosis	0.000284	0.00151	CcSEcCtD
Isoniazid—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000282	0.00889	CbGpPWpGaD
Isoniazid—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000282	0.00889	CbGpPWpGaD
Isoniazid—Paraesthesia—Prednisone—multiple sclerosis	0.000282	0.00149	CcSEcCtD
Isoniazid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00028	0.00881	CbGpPWpGaD
Isoniazid—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00028	0.00881	CbGpPWpGaD
Isoniazid—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000279	0.00878	CbGpPWpGaD
Isoniazid—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000279	0.00878	CbGpPWpGaD
Isoniazid—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000278	0.00877	CbGpPWpGaD
Isoniazid—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000278	0.00877	CbGpPWpGaD
Isoniazid—Convulsion—Methotrexate—multiple sclerosis	0.000278	0.00148	CcSEcCtD
Isoniazid—Dyspepsia—Prednisone—multiple sclerosis	0.000276	0.00146	CcSEcCtD
Isoniazid—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000276	0.0087	CbGpPWpGaD
Isoniazid—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000276	0.0087	CbGpPWpGaD
Isoniazid—Decreased appetite—Prednisone—multiple sclerosis	0.000273	0.00145	CcSEcCtD
Isoniazid—Rash—Prednisolone—multiple sclerosis	0.000272	0.00144	CcSEcCtD
Isoniazid—Fatigue—Prednisone—multiple sclerosis	0.000271	0.00143	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—multiple sclerosis	0.00027	0.00143	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisone—multiple sclerosis	0.000259	0.00137	CcSEcCtD
Isoniazid—Asthenia—Dexamethasone—multiple sclerosis	0.000259	0.00137	CcSEcCtD
Isoniazid—Asthenia—Betamethasone—multiple sclerosis	0.000259	0.00137	CcSEcCtD
Isoniazid—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000257	0.0081	CbGpPWpGaD
Isoniazid—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000257	0.00136	CcSEcCtD
Isoniazid—Nausea—Prednisolone—multiple sclerosis	0.000257	0.00136	CcSEcCtD
Isoniazid—Vomiting—Triamcinolone—multiple sclerosis	0.000253	0.00134	CcSEcCtD
Isoniazid—Vomiting—Methylprednisolone—multiple sclerosis	0.000252	0.00134	CcSEcCtD
Isoniazid—Rash—Triamcinolone—multiple sclerosis	0.00025	0.00133	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—multiple sclerosis	0.00025	0.00133	CcSEcCtD
Isoniazid—Rash—Methylprednisolone—multiple sclerosis	0.00025	0.00132	CcSEcCtD
Isoniazid—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000249	0.00783	CbGpPWpGaD
Isoniazid—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000249	0.00783	CbGpPWpGaD
Isoniazid—Body temperature increased—Prednisone—multiple sclerosis	0.000248	0.00132	CcSEcCtD
Isoniazid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000239	0.00753	CbGpPWpGaD
Isoniazid—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000239	0.00753	CbGpPWpGaD
Isoniazid—Nausea—Triamcinolone—multiple sclerosis	0.000236	0.00125	CcSEcCtD
Isoniazid—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000236	0.00743	CbGpPWpGaD
Isoniazid—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000236	0.00743	CbGpPWpGaD
Isoniazid—Paraesthesia—Methotrexate—multiple sclerosis	0.000236	0.00125	CcSEcCtD
Isoniazid—Nausea—Methylprednisolone—multiple sclerosis	0.000235	0.00125	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisone—multiple sclerosis	0.000231	0.00123	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—multiple sclerosis	0.000231	0.00122	CcSEcCtD
Isoniazid—Vomiting—Betamethasone—multiple sclerosis	0.000229	0.00121	CcSEcCtD
Isoniazid—Vomiting—Dexamethasone—multiple sclerosis	0.000229	0.00121	CcSEcCtD
Isoniazid—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000229	0.0072	CbGpPWpGaD
Isoniazid—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000229	0.0072	CbGpPWpGaD
Isoniazid—Decreased appetite—Methotrexate—multiple sclerosis	0.000228	0.00121	CcSEcCtD
Isoniazid—Rash—Dexamethasone—multiple sclerosis	0.000227	0.0012	CcSEcCtD
Isoniazid—Rash—Betamethasone—multiple sclerosis	0.000227	0.0012	CcSEcCtD
Isoniazid—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000227	0.00714	CbGpPWpGaD
Isoniazid—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000227	0.00714	CbGpPWpGaD
Isoniazid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000226	0.0012	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—multiple sclerosis	0.000226	0.0012	CcSEcCtD
Isoniazid—Asthenia—Prednisone—multiple sclerosis	0.000225	0.00119	CcSEcCtD
Isoniazid—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	0.000217	0.00682	CbGpPWpGaD
Isoniazid—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	0.000217	0.00682	CbGpPWpGaD
Isoniazid—Feeling abnormal—Methotrexate—multiple sclerosis	0.000216	0.00115	CcSEcCtD
Isoniazid—Nausea—Betamethasone—multiple sclerosis	0.000214	0.00113	CcSEcCtD
Isoniazid—Nausea—Dexamethasone—multiple sclerosis	0.000214	0.00113	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—multiple sclerosis	0.000207	0.0011	CcSEcCtD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000205	0.00645	CbGpPWpGaD
Isoniazid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000205	0.00645	CbGpPWpGaD
Isoniazid—Vomiting—Prednisone—multiple sclerosis	0.0002	0.00106	CcSEcCtD
Isoniazid—Rash—Prednisone—multiple sclerosis	0.000198	0.00105	CcSEcCtD
Isoniazid—NAT2—Metabolism—SRM—multiple sclerosis	0.000196	0.00618	CbGpPWpGaD
Isoniazid—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000194	0.0061	CbGpPWpGaD
Isoniazid—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000194	0.0061	CbGpPWpGaD
Isoniazid—Hypersensitivity—Methotrexate—multiple sclerosis	0.000193	0.00102	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—multiple sclerosis	0.000188	0.000998	CcSEcCtD
Isoniazid—Nausea—Prednisone—multiple sclerosis	0.000186	0.000988	CcSEcCtD
Isoniazid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000184	0.00581	CbGpPWpGaD
Isoniazid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000184	0.00581	CbGpPWpGaD
Isoniazid—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000182	0.00573	CbGpPWpGaD
Isoniazid—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000182	0.00573	CbGpPWpGaD
Isoniazid—NAT2—Biological oxidations—POMC—multiple sclerosis	0.000182	0.00572	CbGpPWpGaD
Isoniazid—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000171	0.00539	CbGpPWpGaD
Isoniazid—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000171	0.00539	CbGpPWpGaD
Isoniazid—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000169	0.00532	CbGpPWpGaD
Isoniazid—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000169	0.00532	CbGpPWpGaD
Isoniazid—Vomiting—Methotrexate—multiple sclerosis	0.000167	0.000884	CcSEcCtD
Isoniazid—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000166	0.00521	CbGpPWpGaD
Isoniazid—Rash—Methotrexate—multiple sclerosis	0.000165	0.000877	CcSEcCtD
Isoniazid—Nausea—Methotrexate—multiple sclerosis	0.000156	0.000826	CcSEcCtD
Isoniazid—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00015	0.00471	CbGpPWpGaD
Isoniazid—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00015	0.00471	CbGpPWpGaD
Isoniazid—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000148	0.00466	CbGpPWpGaD
Isoniazid—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000148	0.00466	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000146	0.0046	CbGpPWpGaD
Isoniazid—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000146	0.0046	CbGpPWpGaD
Isoniazid—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000144	0.00454	CbGpPWpGaD
Isoniazid—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000144	0.00453	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—CYP24A1—multiple sclerosis	0.000138	0.00435	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—CYP27B1—multiple sclerosis	0.000138	0.00435	CbGpPWpGaD
Isoniazid—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000132	0.00416	CbGpPWpGaD
Isoniazid—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000132	0.00416	CbGpPWpGaD
Isoniazid—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000132	0.00416	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00013	0.0041	CbGpPWpGaD
Isoniazid—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00013	0.0041	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000129	0.00405	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—GPC5—multiple sclerosis	0.000126	0.00398	CbGpPWpGaD
Isoniazid—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000123	0.00388	CbGpPWpGaD
Isoniazid—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000122	0.00383	CbGpPWpGaD
Isoniazid—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000122	0.00383	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.00012	0.00379	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.00012	0.00379	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00012	0.00377	CbGpPWpGaD
Isoniazid—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00012	0.00377	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000119	0.00374	CbGpPWpGaD
Isoniazid—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000119	0.00374	CbGpPWpGaD
Isoniazid—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000114	0.00358	CbGpPWpGaD
Isoniazid—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000113	0.00357	CbGpPWpGaD
Isoniazid—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000112	0.00353	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—RRM1—multiple sclerosis	0.000105	0.0033	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000103	0.00324	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000103	0.00324	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000102	0.0032	CbGpPWpGaD
Isoniazid—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000102	0.0032	CbGpPWpGaD
Isoniazid—CYP2A6—cerebellum—multiple sclerosis	9.75e-05	0.0342	CbGeAlD
Isoniazid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	9.51e-05	0.00299	CbGpPWpGaD
Isoniazid—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.18e-05	0.00289	CbGpPWpGaD
Isoniazid—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.95e-05	0.00282	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.94e-05	0.0025	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.94e-05	0.0025	CbGpPWpGaD
Isoniazid—CYP2A6—brain—multiple sclerosis	7.92e-05	0.0278	CbGeAlD
Isoniazid—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.84e-05	0.00247	CbGpPWpGaD
Isoniazid—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.84e-05	0.00247	CbGpPWpGaD
Isoniazid—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.73e-05	0.00244	CbGpPWpGaD
Isoniazid—CYP2D6—brainstem—multiple sclerosis	7.4e-05	0.026	CbGeAlD
Isoniazid—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.25e-05	0.00228	CbGpPWpGaD
Isoniazid—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.9e-05	0.00217	CbGpPWpGaD
Isoniazid—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	6.6e-05	0.00208	CbGpPWpGaD
Isoniazid—CYP2E1—medulla oblongata—multiple sclerosis	6.52e-05	0.0229	CbGeAlD
Isoniazid—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.35e-05	0.002	CbGpPWpGaD
Isoniazid—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.29e-05	0.00198	CbGpPWpGaD
Isoniazid—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.27e-05	0.00197	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—BCHE—multiple sclerosis	6.01e-05	0.00189	CbGpPWpGaD
Isoniazid—CYP2E1—spinal cord—multiple sclerosis	5.81e-05	0.0204	CbGeAlD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.68e-05	0.00179	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.68e-05	0.00179	CbGpPWpGaD
Isoniazid—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.59e-05	0.00176	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	5.53e-05	0.00174	CbGpPWpGaD
Isoniazid—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.38e-05	0.00169	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—SRM—multiple sclerosis	5.26e-05	0.00166	CbGpPWpGaD
Isoniazid—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.15e-05	0.00162	CbGpPWpGaD
Isoniazid—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.1e-05	0.00161	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.07e-05	0.0016	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.07e-05	0.0016	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.94e-05	0.00155	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.92e-05	0.00155	CbGpPWpGaD
Isoniazid—CYP2E1—nervous system—multiple sclerosis	4.9e-05	0.0172	CbGeAlD
Isoniazid—CYP2A6—Biological oxidations—POMC—multiple sclerosis	4.87e-05	0.00154	CbGpPWpGaD
Isoniazid—CYP2E1—central nervous system—multiple sclerosis	4.72e-05	0.0165	CbGeAlD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.63e-05	0.00146	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.63e-05	0.00146	CbGpPWpGaD
Isoniazid—CYP2E1—cerebellum—multiple sclerosis	4.61e-05	0.0162	CbGeAlD
Isoniazid—CYP2C8—brain—multiple sclerosis	4.45e-05	0.0156	CbGeAlD
Isoniazid—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.36e-05	0.00137	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—SRM—multiple sclerosis	4.16e-05	0.00131	CbGpPWpGaD
Isoniazid—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.15e-05	0.00131	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.95e-05	0.00125	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.95e-05	0.00125	CbGpPWpGaD
Isoniazid—CYP3A4—nervous system—multiple sclerosis	3.94e-05	0.0138	CbGeAlD
Isoniazid—CYP2D6—nervous system—multiple sclerosis	3.88e-05	0.0136	CbGeAlD
Isoniazid—CYP2E1—Biological oxidations—POMC—multiple sclerosis	3.85e-05	0.00121	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.84e-05	0.00121	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.84e-05	0.00121	CbGpPWpGaD
Isoniazid—CYP3A4—central nervous system—multiple sclerosis	3.79e-05	0.0133	CbGeAlD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.76e-05	0.00118	CbGpPWpGaD
Isoniazid—CYP2E1—brain—multiple sclerosis	3.74e-05	0.0131	CbGeAlD
Isoniazid—CYP2D6—central nervous system—multiple sclerosis	3.73e-05	0.0131	CbGeAlD
Isoniazid—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	3.71e-05	0.00117	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	3.71e-05	0.00117	CbGpPWpGaD
Isoniazid—CYP2D6—cerebellum—multiple sclerosis	3.65e-05	0.0128	CbGeAlD
Isoniazid—NAT2—Metabolism—APOE—multiple sclerosis	3.62e-05	0.00114	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—SRM—multiple sclerosis	3.59e-05	0.00113	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.58e-05	0.00113	CbGpPWpGaD
Isoniazid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.58e-05	0.00113	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GPC5—multiple sclerosis	3.39e-05	0.00107	CbGpPWpGaD
Isoniazid—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.36e-05	0.00106	CbGpPWpGaD
Isoniazid—CYP2C8—Biological oxidations—POMC—multiple sclerosis	3.33e-05	0.00105	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SRM—multiple sclerosis	3.21e-05	0.00101	CbGpPWpGaD
Isoniazid—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	3.2e-05	0.00101	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—POMC—multiple sclerosis	3.11e-05	0.000979	CbGpPWpGaD
Isoniazid—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.97e-05	0.000936	CbGpPWpGaD
Isoniazid—CYP2D6—brain—multiple sclerosis	2.96e-05	0.0104	CbGeAlD
Isoniazid—CYP2D6—Metabolism—SRM—multiple sclerosis	2.95e-05	0.000929	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.93e-05	0.000922	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.93e-05	0.000922	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SRM—multiple sclerosis	2.92e-05	0.000921	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—ALB—multiple sclerosis	2.83e-05	0.000892	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—RRM1—multiple sclerosis	2.81e-05	0.000885	CbGpPWpGaD
Isoniazid—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.73e-05	0.000861	CbGpPWpGaD
Isoniazid—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.71e-05	0.000853	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.68e-05	0.000844	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	2.53e-05	0.000797	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	2.53e-05	0.000797	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SRM—multiple sclerosis	2.5e-05	0.000787	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.47e-05	0.000779	CbGpPWpGaD
Isoniazid—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.32e-05	0.000729	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.32e-05	0.000729	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.26e-05	0.000712	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.26e-05	0.000712	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.22e-05	0.000699	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.21e-05	0.000696	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.000655	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.000655	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.07e-05	0.000651	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.06e-05	0.000649	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.06e-05	0.000649	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.01e-05	0.000634	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SRM—multiple sclerosis	1.93e-05	0.000607	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.92e-05	0.000604	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.9e-05	0.000599	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.88e-05	0.000593	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.79e-05	0.000563	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.76e-05	0.000554	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.76e-05	0.000554	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.72e-05	0.000542	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.71e-05	0.000539	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000508	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.61e-05	0.000507	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.57e-05	0.000496	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.56e-05	0.000492	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.49e-05	0.000469	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.36e-05	0.000428	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.36e-05	0.000428	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.33e-05	0.00042	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.33e-05	0.000418	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.28e-05	0.000403	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.27e-05	0.000401	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.24e-05	0.000391	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.21e-05	0.000382	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.17e-05	0.000367	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.14e-05	0.000359	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000347	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.04e-05	0.000328	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.04e-05	0.000328	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.04e-05	0.000326	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.03e-05	0.000324	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—BCHE—multiple sclerosis	9.83e-06	0.00031	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—APOE—multiple sclerosis	9.7e-06	0.000306	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.49e-06	0.000299	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.05e-06	0.000285	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—BCHE—multiple sclerosis	8.97e-06	0.000282	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.89e-06	0.00028	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—POMC—multiple sclerosis	8.34e-06	0.000263	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.11e-06	0.000255	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—APOE—multiple sclerosis	7.67e-06	0.000242	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—BCHE—multiple sclerosis	7.66e-06	0.000241	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ALB—multiple sclerosis	7.6e-06	0.000239	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—APOE—multiple sclerosis	6.63e-06	0.000209	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—POMC—multiple sclerosis	6.59e-06	0.000207	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ALB—multiple sclerosis	6.01e-06	0.000189	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—APOE—multiple sclerosis	5.92e-06	0.000186	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.91e-06	0.000186	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—POMC—multiple sclerosis	5.69e-06	0.000179	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—APOE—multiple sclerosis	5.44e-06	0.000171	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—APOE—multiple sclerosis	5.39e-06	0.00017	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ALB—multiple sclerosis	5.19e-06	0.000164	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—POMC—multiple sclerosis	5.08e-06	0.00016	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—POMC—multiple sclerosis	4.67e-06	0.000147	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—POMC—multiple sclerosis	4.63e-06	0.000146	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ALB—multiple sclerosis	4.63e-06	0.000146	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—APOE—multiple sclerosis	4.61e-06	0.000145	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ALB—multiple sclerosis	4.26e-06	0.000134	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ALB—multiple sclerosis	4.22e-06	0.000133	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—POMC—multiple sclerosis	3.96e-06	0.000125	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALB—multiple sclerosis	3.61e-06	0.000114	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—APOE—multiple sclerosis	3.56e-06	0.000112	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—POMC—multiple sclerosis	3.06e-06	9.63e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALB—multiple sclerosis	2.79e-06	8.78e-05	CbGpPWpGaD
